For example, HOXA11-AS can act as an oncogene in non-small cell lung cancer (NSCLC), hepatocellular carcinoma (HCC), glioma, breast cancer (BC), gastric cancer (GC), kidney cancer (RC), uveal melanoma (UM), laryngeal squamous cell carcinoma (LSCC), cervical cancer (CC), esophageal squamous cell carcinoma (ESCC), and osteosarcoma [16, 41–47]. The gene discussed is HOXA11; the disease is central nervous system cancer.